English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12189/12972 (94%)
Visitors : 973493 Online Users : 908
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
分子與基因醫學研究所
生技與藥物研究所
生醫工程與奈米醫學研究所
免疫醫學研究中心
神經及精神醫學研究中心
細胞及系統醫學研究所
感染症與疫苗研究所
群體健康科學研究所
癌症研究所
國家環境醫學研究所
國家蚊媒傳染病防治研究中心
高齡醫學暨健康福祉研究中心
論壇
生醫資源中心
研究生培育合作學程
核心儀器設施中心
病理核心實驗室
實驗動物中心
行政管理部門
圖書館
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
Items for Type
Loading...
Category
Loading community tree, please wait....
Year
Loading year class tree, please wait....
Items for Type "meeting abstract"
Return toBrowse by Content Type
Showing 25 items.
Showing items 1076-1100 of 1382. (56 Page(s) Totally)
<<
<
39
40
41
42
43
44
45
46
47
48
>
>>
View [
10
|
25
|
50
] records per page
Collection
Date
Title
Relation
Bitstream
[其他] 會議論文/會議摘要
2019-04
Long-term clinical outcomes of IMRT with simultaneous integrated boost for breast cancer
-
[劉滄梧] 會議論文/會議摘要
2017-05
Prevalence and estimated trend in chemotherapy use near death from population-based studies on cancer patients: A systematic review and meta-analysis
-
[劉玉麗] 會議論文/會議摘要
2019-01
Identifying variants in nf1a gene to be associated with seasonal pattern and susceptibility for depression through a candidate gene approach
-
[劉玉麗] 會議論文/會議摘要
2019-01
Distinct genetic profiles of peptic ulcer in individuals with depression
-
[劉玉麗] 會議論文/會議摘要
2019-01
Identification of genetic variants for suicidal behaviors in patients with bipolar or major depressive disorders
-
[姜乃榕] 期刊論文
2017-05
A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy
-
[常慧如] 會議論文/會議摘要
2017-05
Second malignant neoplasms in a nationwide population-based cohort of childhood cancer survivors in Taiwan
-
[張光裕] 會議論文/會議摘要
2018-07
Mitochondrial SOD2 is the mainstay to protect the stemness-featured glioblastoma cells against drug-induced reactive oxygen stress
-
[張光裕] 會議論文/會議摘要
2018-07
Sp1 acetylation associates with stemness characteristics in temozolomide-resistant glioblastoma
-
[張光裕] 會議論文/會議摘要
2018-07
Oleic acid promotes head and neck squamous cell carcinoma anoikis resistance and metastasis via ANGPTL4/fibronectin pathway
-
[施能耀] 會議論文/會議摘要
2018-07
Salt-inducible kinase 3 expression identifies long-term survivors of serous ovarian cancer
-
[松浦功] 會議論文/會議摘要
2018-07
Repression of CD44 expression by p53 in a breast cancer progression model
-
[楊良棟] 會議論文/會議摘要
2019-05
Gasdermin A3-mediated cell death causes niche collapse and precocious activation of hair follicle stem cells
-
[溫啟邦(2001-2010)] 會議論文/會議摘要
2018-10
Smokers with diabetes: Twice as deadly and shortened life by 15 years
-
[翁紹華] 會議論文/會議摘要
2018-07
4-Bromophenylhydrazinyl benzenesulfonylphenylureas inhibit indoleamine 2,3-dioxygenase in vitro and in vivo
-
[蔡世峯] 會議論文/會議摘要
2018-07
GATA3 mutation of luminal-type breast cancer patients in Taiwan
-
[謝興邦] 會議論文/會議摘要
2018-07
Clinical candidate DBPR112: A novel epidermal growth factor receptor inhibitor as a promising treatment for non-small cell lung cancer
-
[郭靜娟] 會議論文/會議摘要
2018-07
Blockage of EGFR signaling repurposes tumor metabolism through suppression of glycolysis and Kreb cycle in head and neck cancer
-
[陳立宗] 會議論文/會議摘要
2017-02
Nivolumab (ONO-4538/BMS-936558) as salvage treatment after second or later-line chemotherapy for advanced gastric or gastroesophageal junction cancer (AGC): A double-blinded, randomized, phase III trial
-
[陳立宗] 會議論文/會議摘要
2017-05
The prognostic value of baseline neutrophilto-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for predicting clinical outcome in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan (nal-IRI; MM
-
[陳立宗] 會議論文/會議摘要
2017-02
Characteristics of long-term survivors in a randomized phase III trial (NAPOLI-1) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan (nal-IRI; MM-398)+5-FU/LV
-
[陳立宗] 會議論文/會議摘要
2016-05
Updated overall survival (OS) analysis of NAPOLI-1: Phase 3 study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine
-
[陳立宗] 會議論文/會議摘要
2016-05
Effect of baseline carbohydrate antigen 19-9 (CA19-9) level on overall survival (OS) in NAPOLI-1: A randomized phase III study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine (gem)-based therapy
-
[陳立宗] 會議論文/會議摘要
2016-05
Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)
-
[陳立宗] 會議論文/會議摘要
2016-05
Quality-adjusted time without symptoms or toxicity (Q-TWiST) of nanoliposomal irinotecan (nal-IRI; MM-398) plus 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alone in metastatic pancreatic adenocarcinoma (mPAC) patients (pts) previously treated with
-
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback